Form
Fill Out The Form To Begin Your Download
Lipid nanoparticles (LNPs) offer significant advantages as a delivery system for a nucleic-acids therapeutics. In addition to functional advantages, such as biocompatibility, biodegradability and high entrapment efficency, LNPs can be manufactured rapidly, reproducibly, and with high scalability. At Curapath, we optimize LNP formulation during pre-clinical research and development in order to determine the optimal conditions for the encapsulation of nucleic acids.
Support for Your Therapeutic Program
Contact a Chemist Today
Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.